Lumen Bioscience
Lumen Bioscience engineers the edible algae spirulina to produce therapeutic proteins for orally delivered biologic drugs, as well as ingredients for human and animal nutrition. Its platform is intended to make biologic medicines faster and less costly to develop and more accessible to patients.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2017
- Type
- Corporation Seattle business license
- Employees
- 104
- Registered name
- Lumen Bioscience Inc Seattle business license
- Stage
- Series C
- Founders
- Brian Finrow, Jim Roberts
Is this your organization? Claim it
Seattle Biotech Lumen Bioscience Raises $30M Series C Extension, Adds Microsoft Vet Jeff Raikes to Board
Seattle biotech startup Lumen Bioscience raised a $30 million Series C extension led by WestRiver Group, bringing total funding to $186.8 million to advance its oral biologic drugs. The company also added Microsoft veteran Jeff Raikes to its board and announced several leadership updates.
Lumen Bioscience adds Jeff Raikes to board, promotes executives and secures $30M Series C extension led by WestRiver Group
Lumen Bioscience announced board and leadership changes—including Jeff Raikes joining as an independent director, promotions of Nhi Khuong and Kole Krieger, and appointment of David Saunders—and elected Erik Anderson as Vice Chairman. The company also closed an oversubscribed $30 million Series C extension led by WestRiver Group with participation from the Gates Foundation and several new investors to support its orally delivered biologics clinical pipeline.
A-Alpha Bio raises $20M Series A led by Madrona to expand Seattle lab and scale protein-discovery platform
University of Washington spinout A-Alpha Bio raised $20 million in Series A funding led by Madrona Venture Group to expand downtown Seattle lab space and grow its machine-learning team for its protein-discovery platform. The company combines computational tools and yeast-based experiments to generate large protein-interaction datasets used to predict therapeutic protein candidates for diseases including COVID-19.
People
-
Brian Finrow Co-Founder and Chief Executive Officer
-
Jim Roberts Co-Founder and Chief Scientific Officer
Online
Questions about Lumen Bioscience
What is Lumen Bioscience?
Lumen Bioscience is a startup based in Seattle that engineers the edible algae spirulina to produce therapeutic proteins for orally delivered biologic drugs and ingredients for human and animal nutrition.
What has Lumen Bioscience been in the news for?
WestRiver Group reported in October 2025 that Lumen Bioscience promoted executives.
Who are the people behind Lumen Bioscience?
Brian Finrow is co-founder and chief executive officer of Lumen Bioscience. Jim Roberts is co-founder and chief scientific officer.
Who invested in Lumen Bioscience, and how much has it raised?
Members of Seattle Flow see Lumen Bioscience's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Lumen Bioscience based?
Lumen Bioscience is based in Seattle.
When was Lumen Bioscience founded?
Lumen Bioscience was founded in 2017.